Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
Diagn Microbiol Infect Dis. 2012 Feb;72(2):139-43. doi: 10.1016/j.diagmicrobio.2011.10.009. Epub 2011 Dec 5.
Pneumocystis jirovecii is an important opportunistic infection in human immunodeficiency virus (HIV)-infected patients. In the developed world, P. jirovecii epidemiology is marked by frequent colonization in immunosuppressed patients, but data on the prevalence of colonization are very limited in sub-Saharan Africa, where the majority of persons living with HIV reside. Our objective was to describe the epidemiology of P. jirovecii colonization among HIV-positive patients in a cross-sectional, hospital-based study of patients admitted with suspected pneumonia in Kampala, Uganda. P. jirovecii was detectable in bronchoalveolar lavage fluid from 7 (6%) of 124 consecutive patients with non-Pneumocystis pneumonia. Colonization was not associated with patient demographic or clinical information. This prevalence is substantially lower than in published studies in the developed world and suggests that there is a limited reservoir of organisms for clinical infections in this Ugandan population. These findings may partially explain the low incidence of Pneumocystis pneumonia in Uganda and other sub-Saharan African countries.
肺孢子菌是人类免疫缺陷病毒(HIV)感染患者的一种重要机会性感染。在发达国家,肺孢子菌的流行病学特点是免疫抑制患者中频繁定植,但在撒哈拉以南非洲,关于肺孢子菌定植的流行率数据非常有限,而该地区是大多数 HIV 感染者的所在地。我们的目的是描述在乌干达坎帕拉进行的一项横断面、基于医院的研究中,HIV 阳性患者中肺孢子菌定植的流行病学情况,该研究纳入了因疑似肺炎入院的患者。在 124 例连续的非肺孢子菌性肺炎患者的支气管肺泡灌洗液中,有 7 例(6%)可检测到肺孢子菌。定植与患者的人口统计学或临床信息无关。这一流行率明显低于已发表的发达国家的研究,表明在乌干达人群中,用于临床感染的病原体储备有限。这些发现部分解释了在乌干达和其他撒哈拉以南非洲国家中肺孢子菌肺炎发病率较低的原因。